ID: ALA2391055

Max Phase: Preclinical

Molecular Formula: C19H14F2N2O2S

Molecular Weight: 372.40

Molecule Type: Small molecule

Representations

Canonical SMILES:  Cc1c(C#N)cc(-c2ccc(S(C)(=O)=O)cc2)n1-c1ccc(F)c(F)c1

Standard InChI:  InChI=1S/C19H14F2N2O2S/c1-12-14(11-22)9-19(13-3-6-16(7-4-13)26(2,24)25)23(12)15-5-8-17(20)18(21)10-15/h3-10H,1-2H3

Standard InChI Key:  JAXSFVHEUPGKCY-UHFFFAOYSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 372.40

Molecular Weight (Monoisotopic): 372.0744

AlogP: 4.01

#Rotatable Bonds: 3

Polar Surface Area: 62.86

Molecular Species: NEUTRAL

HBA: 4

HBD: 0

#RO5 Violations: 0

HBA (Lipinski): 4

HBD (Lipinski): 0

#RO5 Violations (Lipinski): 0

CX Acidic pKa:

CX Basic pKa:

CX LogP: 3.68

CX LogD: 3.68

Aromatic Rings: 3

Heavy Atoms: 26

QED Weighted: 0.70

Np Likeness Score: -1.84

References

1. Battilocchio C, Poce G, Alfonso S, Porretta GC, Consalvi S, Sautebin L, Pace S, Rossi A, Ghelardini C, Di Cesare Mannelli L, Schenone S, Giordani A, Di Francesco L, Patrignani P, Biava M..  (2013)  A class of pyrrole derivatives endowed with analgesic/anti-inflammatory activity.,  21  (13): [PMID:23680444] [10.1016/j.bmc.2013.04.031]

Source

Source(1):

• Scientific Literature